Notification of Major Interests in Shares

Nigel Wray acquires additional shares in Alliance Pharma

On 5 May 2005, the company was notified by Nigel Wray that he has purchased an
additional 700,000 shares in the company bringing his total holdings in Alliance
Pharma to 6,355,407 ordinary shares or 4.31% of the issued share capital.

-ENDS-

For further information:

Alliance Pharma plc     + 44 (0) 1249 466966

John Dawson, Chief Executive
Maddy Scott, Finance Director
www.alliancepharma.co.uk

Numis Securities          + 44 (0) 20 7776 1500
David Poutney

Buchanan Communications   + 44 (0) 20 7466 5000
Mark Court/Lisa Baderoon/Rebecca Skye Dietrich

      This information is provided by RNS
The company news service from the London
Stock Exchange